Azzad Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Sell
85,725
-985
-1% -$114K 1.04% 9
2025
Q4
$9.13M Buy
86,710
+711
+0.8% +$66.7K 0.9% 9
2025
Q3
$7.22M Buy
85,999
+3,366
+4% +$277K 0.71% 16
2025
Q2
$6.54M Buy
82,633
+2,154
+3% +$171K 0.7% 15
2025
Q1
$7.22M Buy
80,479
+25,083
+45% +$2.34M 0.85% 11
2024
Q4
$5.51M Buy
55,396
+11,023
+25% +$1.14M 1.06% 17
2024
Q3
$5.04M Buy
44,373
+603
+1% +$71.6K 0.57% 35
2024
Q2
$5.42M Sell
43,770
-15,614
-26% -$2.01M 0.64% 23
2024
Q1
$7.84M Buy
59,384
+1,070
+2% +$132K 0.91% 11
2023
Q4
$6.36M Buy
58,314
+83
+0.1% +$8.62K 0.8% 14
2023
Q3
$5.99M Buy
58,231
+3,886
+7% +$419K 0.85% 12
2023
Q2
$6.27M Sell
54,345
-6,019
-10% -$683K 0.84% 12
2023
Q1
$6.42M Sell
60,364
-4,963
-8% -$536K 0.92% 12
2022
Q4
$7.25M Sell
65,327
-15,234
-19% -$1.56M 1.15% 6
2022
Q3
$6.8M Sell
80,561
-9,296
-10% -$830K 0.68% 20
2022
Q2
$7.97M Buy
89,857
+19,399
+28% +$1.72M 0.79% 11
2022
Q1
$5.78M Buy
70,458
+6,909
+11% +$545K 0.83% 13
2021
Q4
$4.87M Sell
63,549
-190
-0.3% -$15.1K 0.65% 24
2021
Q3
$4.79M Buy
63,739
+5,723
+10% +$435K 0.71% 17
2021
Q2
$4.51M Buy
58,016
+31,132
+116% +$2.32M 0.67% 21
2021
Q1
$1.98M Buy
26,884
+3,065
+13% +$226K 0.33% 115
2020
Q4
$1.86M Buy
23,819
+6,086
+34% +$465K 0.34% 116
2020
Q3
$1.4M Buy
17,733
+780
+5% +$61.1K 0.29% 132
2020
Q2
$1.25M Sell
16,953
-436
-3% -$32.8K 0.29% 132
2020
Q1
$1.28M Sell
17,389
-16,673
-49% -$1.31M 0.37% 98
2019
Q4
$2.74M Buy
34,062
+176
+0.5% +$14.5K 0.32% 107
2019
Q3
$2.61M Buy
33,886
+17,117
+102% +$1.37M 0.32% 105
2019
Q2
$1.34M Sell
16,769
-612
-4% -$46.9K 0.37% 99
2019
Q1
$1.38M Sell
17,381
-178
-1% -$13.3K 0.4% 88
2018
Q4
$1.28M Sell
17,559
-1,105
-6% -$78K 0.43% 79
2018
Q3
$1.26M Buy
18,664
+1,713
+10% +$109K 0.34% 108
2018
Q2
$982K Sell
16,951
-275
-2% -$15.5K 0.28% 140
2018
Q1
$895K Sell
17,226
-7,396
-30% -$399K 0.27% 144
2017
Q4
$1.32M Buy
24,622
+4,102
+20% +$227K 0.42% 80
2017
Q3
$1.25M Buy
20,520
+650
+3% +$39.4K 0.42% 80
2017
Q2
$1.22M Buy
19,870
+1,102
+6% +$67.1K 0.44% 80
2017
Q1
$1.14M Buy
18,768
+868
+5% +$52.7K 0.43% 85
2016
Q4
$1.01M Buy
17,900
+749
+4% +$43.8K 0.41% 83
2016
Q3
$1.02M Buy
17,151
+2,828
+20% +$165K 0.42% 91
2016
Q2
$787K Buy
14,323
+814
+6% +$43.3K 0.34% 112
2016
Q1
$682K Buy
13,509
+1,199
+10% +$58.7K 0.3% 131
2015
Q4
$620K Buy
12,310
+5,176
+73% +$261K 0.3% 130
2015
Q3
$336K Buy
7,134
+444
+7% +$23.6K 0.18% 196
2015
Q2
$363K Sell
6,690
-32
-0.5% -$1.79K 0.18% 197
2015
Q1
$369K Buy
6,722
+337
+5% +$19.1K 0.18% 202
2014
Q4
$346K Buy
6,385
+367
+6% +$20.4K 0.18% 217
2014
Q3
$340K Buy
6,018
+231
+4% +$13K 0.2% 208
2014
Q2
$319K Buy
5,787
+63
+1% +$3.44K 0.19% 211
2014
Q1
$310K Buy
5,724
+290
+5% +$15K 0.2% 212
2013
Q4
$260K Buy
5,434
+283
+5% +$12.9K 0.19% 213
2013
Q3
$234K Hold
5,151
0.19% 202
2013
Q2
$234K Buy
+5,151
New +$230K 0.2% 199

Other funds holding MRK

Azzad Asset Management's MRK Position: Q1 2026 in Review

Azzad Asset Management reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $114K and leaving 85,725 shares worth $10.3M. The position accounts for 1.04% of the portfolio, ranked #9.

Azzad Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Azzad Asset Management held 85,725 shares of Merck worth $10.3M as of Q1 2026.
  • Azzad Asset Management sold 985 Merck shares in Q1 2026, an estimated $114K.
  • Merck made up 1.04% of Azzad Asset Management's portfolio in Q1 2026, its #9 holding.
  • Azzad Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.